Literature DB >> 25575367

The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications.

Victor Kim1, Gerard J Criner.   

Abstract

PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) is a major public health problem that is projected to rank fifth worldwide in terms of disease burden and third in terms of mortality. Chronic bronchitis is associated with multiple clinical consequences, including hastening lung function decline, increasing risk of exacerbations, reducing health-related quality of life, and possibly raising all-cause mortality. Recent data suggest greater elucidation on the risk factors, radiologic characteristics, and treatment regimens. Our goal was to review the literature on chronic bronchitis that has been published in the past few years. RECENT
FINDINGS: A growing body of literature that more carefully describes environmental risk factors, epidemiology, and genetics associated with chronic bronchitis. In addition, as computed tomography technology continues to improve, the radiologic phenotype associated with chronic bronchitis is better understood.
SUMMARY: With these new data, the clinician can recognize the newly described risk factors and the associated phenotype for chronic bronchitis and entertain new treatment options for this high-risk population.

Entities:  

Mesh:

Year:  2015        PMID: 25575367      PMCID: PMC4373868          DOI: 10.1097/MCP.0000000000000145

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  76 in total

1.  Chronic mucus hypersecretion: prevalence and risk factors in younger individuals.

Authors:  L Harmsen; S F Thomsen; T Ingebrigtsen; I E Steffensen; L R Skadhauge; K O Kyvik; V Backer
Journal:  Int J Tuberc Lung Dis       Date:  2010-08       Impact factor: 2.373

2.  Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China.

Authors:  Ming Lu; Wanzhen Yao; Nanshan Zhong; Yumin Zhou; Chen Wang; Ping Chen; Jian Kang; Shaoguang Huang; Baoyuan Chen; Changzheng Wang; Diantao Ni; Xiaoping Wang; Dali Wang; Shengming Liu; Jiachun Lu; Ning Shen; Pixin Ran
Journal:  Respirology       Date:  2010-08-16       Impact factor: 6.424

Review 3.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

Review 4.  Cough and sputum production as risk factors for poor outcomes in patients with COPD.

Authors:  Marc Miravitlles
Journal:  Respir Med       Date:  2011-02-25       Impact factor: 3.415

5.  Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men.

Authors:  Margit Pelkonen; Irma-Leena Notkola; Aulikki Nissinen; Hannu Tukiainen; Heikki Koskela
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

6.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

7.  Seven-year cumulative incidence of COPD in an age-stratified general population sample.

Authors:  Anne Lindberg; Berne Eriksson; Lars-Gunnar Larsson; Eva Rönmark; Thomas Sandström; Bo Lundbäck
Journal:  Chest       Date:  2006-04       Impact factor: 9.410

8.  Predictors of COPD symptoms: does the sex of the patient matter?

Authors:  L Watson; J P Schouten; C-G Löfdahl; N B Pride; L A Laitinen; D S Postma
Journal:  Eur Respir J       Date:  2006-05-17       Impact factor: 16.671

9.  Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Authors:  Jin-Ping Zheng; Fu-Qiang Wen; Chun-Xue Bai; Huan-Ying Wan; Jian Kang; Ping Chen; Wan-Zhen Yao; Li-Jun Ma; Xia Li; Luca Raiteri; Marco Sardina; Yi Gao; Bai-Song Wang; Nan-Shan Zhong
Journal:  Lancet Respir Med       Date:  2014-01-30       Impact factor: 30.700

10.  Characterisation of COPD heterogeneity in the ECLIPSE cohort.

Authors:  Alvar Agusti; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Lisa D Edwards; David A Lomas; William MacNee; Bruce E Miller; Steve Rennard; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Julie C Yates; Jørgen Vestbo
Journal:  Respir Res       Date:  2010-09-10
View more
  36 in total

1.  Association of birthplace and occupational exposures with chronic bronchitis in US Hispanics/Latinos, 2008-2011.

Authors:  Victor Kim; Wei Wang; David Mannino; Alejandro Diaz
Journal:  Occup Environ Med       Date:  2020-03-12       Impact factor: 4.402

2.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

3.  The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Authors:  Victor Kim; Huaqing Zhao; Elizabeth Regan; MeiLan K Han; Barry J Make; James D Crapo; Paul W Jones; Jeffrey L Curtis; Edwin K Silverman; Gerard J Criner
Journal:  Chest       Date:  2019-05-15       Impact factor: 9.410

Review 4.  Epithelial-Immune Cell Interactions for Drug Discovery in Chronic Obstructive Pulmonary Disease.

Authors:  Shamus P Keeler; Benjamin J Gerovac; Kangyun Wu; Xinyu Wang; Joshua R Chartock; Derek E Byers; Arthur G Romero; Michael J Holtzman
Journal:  Ann Am Thorac Soc       Date:  2018-12

5.  A Brief History of Bronchitis in England and Wales.

Authors:  Jonathan H Widdicombe
Journal:  Chronic Obstr Pulm Dis       Date:  2020-10

6.  Lower diffusing capacity with chronic bronchitis predicts higher risk of acute exacerbation in chronic obstructive lung disease.

Authors:  Hwa Young Lee; Jin Woo Kim; Sang Haak Lee; Hyoung Kyu Yoon; Jae Jeong Shim; Jeong-Woong Park; Jae-Hyung Lee; Kwang Ha Yoo; Ki-Suck Jung; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

7.  Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease.

Authors:  Tae Hoon Kim; Dong Kyu Oh; Yeon-Mok Oh; Sei Won Lee; Sang Do Lee; Jae Seung Lee
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 3.005

Review 8.  Unknown/enigmatic functions of extracellular ASC.

Authors:  Jean Gabriel de Souza; Nancy Starobinas; Olga Celia Martinez Ibañez
Journal:  Immunology       Date:  2021-06-22       Impact factor: 7.215

9.  Chronic bronchitis is an independently associated factor for more symptom and high-risk groups.

Authors:  Joon Young Choi; Hyoung Kyu Yoon; Seoung Ju Park; Yong Bum Park; Kyeong-Cheol Shin; Ju Ock Na; Kwang Ha Yoo; Ki-Suck Jung; Young Kyoon Kim; Chin Kook Rhee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-21

10.  IL-36 Cytokines Promote Inflammation in the Lungs of Long-Term Smokers.

Authors:  Melissa A Kovach; Karlhans Che; Bettina Brundin; Anders Andersson; Helga Asgeirsdottir; Médea Padra; Sara K Lindén; Ingemar Qvarfordt; Michael W Newstead; Theodore J Standiford; Anders Lindén
Journal:  Am J Respir Cell Mol Biol       Date:  2021-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.